+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hemostats and tissue Sealants Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028

  • Report

  • 100 Pages
  • May 2022
  • Region: Global
  • Infinium Global Research
  • ID: 5605382
The report on the global hemostats and tissue sealants market provides qualitative and quantitative analysis for the period from 2020 to 2028. The report predicts the global hemostats and tissue sealants market to grow with a significant CAGR over the forecast period from 2022-2028. The study on hemostats and tissue sealants market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.

The report on hemostats and tissue sealants market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global hemostats and tissue sealants market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global hemostats and tissue sealants market over the period of 2020 to 2028. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings


1) Drivers

  • Increasing number of surgeries worldwide
  • Increasing popularity of mi procedures

2) Restraints

  • Lack of awareness about these devices

3) Opportunities

  • Development of new tissue sealants and hemostats

Research Methodology


A) Primary Research


The primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders
2. Internal and External subject matter experts
3. Professionals and participants from the industry

The primary research respondents typically include

1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/country managers
5. Vice President level executives.

B) Secondary Research


Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. Each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include

1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered

The global hemostats and tissue sealants market is segmented on the basis of product.

The Global Hemostats and tissue Sealants Market by Product

  • Hemostats
  • Tissue Sealants and Adhesives
  • Fibrin Sealants

Company Profiles


The companies covered in the report include
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Cardinal Health, Inc.
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • CSL Behring LLC
  • Ethicon US, LLC
  • HyperBranch Medical Technology, Inc.
  • Integra Lifesciences Corporation
  • Smith & Nephew PLC

What does this Report Deliver?

1. Comprehensive analysis of the global as well as regional markets of the hemostats and tissue sealants market.
2. Complete coverage of all the segments in the hemostats and tissue sealants market to analyze the trends, developments in the global market and forecast of market size up to 2028.
3. Comprehensive analysis of the companies operating in the global hemostats and tissue sealants market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
2.1. Hemostats and Tissue Sealants Market Highlights
2.2. Hemostats and Tissue Sealants Market Projection
2.3. Hemostats and Tissue Sealants Market Regional Highlights
3. Global Hemostats and Tissue Sealants Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Hemostats and Tissue Sealants Market
3.4. Porter's Five Forces Analysis
3.5. Growth Matrix Analysis
3.5.1. Growth Matrix Analysis by Product
3.5.2. Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Hemostats and Tissue Sealants Market
4. Hemostats and Tissue Sealants Market Macro Indicator Analysis
5. Global Hemostats and Tissue Sealants Market by Product
5.1. Hemostats
5.2. Tissue Sealants and Adhesives
5.3. Fibrin Sealants
6. Global Hemostats and Tissue Sealants Market by Region 2022-2028
6.1. North America
6.1.1. North America Hemostats and Tissue Sealants Market by Product
6.1.2. North America Hemostats and Tissue Sealants Market by Country
6.2. Europe
6.2.1. Europe Hemostats and Tissue Sealants Market by Product
6.2.2. Europe Hemostats and Tissue Sealants Market by Country
6.3. Asia-Pacific
6.3.1. Asia-Pacific Hemostats and Tissue Sealants Market by Product
6.3.2. Asia-Pacific Hemostats and Tissue Sealants Market by Country
6.4. RoW
6.4.1. RoW Hemostats and Tissue Sealants Market by Product
6.4.2. RoW Hemostats and Tissue Sealants Market by Sub-region
7. Company Profiles and Competitive Landscape
7.1. Competitive Landscape in the Global Hemostats and Tissue Sealants Market
7.2. Companies Profiled
7.2.1. BARD, A Becton, Dickinson Company
7.2.2. Baxter International, Inc.
7.2.3. Cardinal Health, Inc.
7.2.4. Cohera Medical, Inc.
7.2.5. CryoLife, Inc.
7.2.6. CSL Behring LLC
7.2.7. Ethicon US, LLC
7.2.8. HyperBranch Medical Technology, Inc.
7.2.9. Integra Lifesciences Corporation
7.2.10. Smith & Nephew PLC

Companies Mentioned

  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Cardinal Health, Inc.
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • CSL Behring LLC
  • Ethicon US, LLC
  • HyperBranch Medical Technology, Inc.
  • Integra Lifesciences Corporation
  • Smith & Nephew PLC